Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000034031Phase 4Recruiting
Phase 4, randomised, single-blind trial of remimazolam (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Success rate of anesthesia and sedation. Started Jul 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000034031.